Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19
Clinical trial NCT04469179 · UNKNOWN
Trial details
- NCT number
- NCT04469179
- Sponsor
- SAb Biotherapeutics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-20
- Primary completion
- 2021-02-25
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.